Acquired DNA mutations and the leukemogenic potential of hydroxyurea therapy.

被引：0
|
作者：
Ware, RE
Hanft, VN
Pickens, CV
Rosse, WF
Fruchtman, SR
Howard, TA
机构：
[1] Duke Univ, Med Ctr, Durham, NC USA
[2] Mt Sinai Med Ctr, New York, NY 10029 USA
来源：
BLOOD | 1998年 / 92卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1752
引用
收藏
页码：424A / 424A
页数：1
相关论文
共 50 条
  • [21] Leukemogenic risk of hydroxyurea (HU) therapy in polycythemia vera (PV), essential thrombocythemia (ET), and myeloid metaplasia with myelofibrosis (MMM).
    Nand, S
    Stock, W
    Godwin, J
    Fisher, S
    BLOOD, 1995, 86 (10) : 3181 - 3181
  • [22] A method for measuring the success potential of cancer therapy.
    Bucovaz, ET
    Macleod, RM
    Morrison, JC
    Whybrew, WD
    FASEB JOURNAL, 1997, 11 (09): : A1251 - A1251
  • [23] Structure and Spectroscopy of Potential Drugs for Photodynamic Therapy.
    Timofeeva, Tatiana V.
    Kinnibrugh, Tiffany L.
    Short, Kurt W.
    Makarov, Michael V.
    Odinets, Irina L.
    Antipin, Mikhail Yu.
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2009, 65 : S103 - S103
  • [24] Characterization of the leukemogenic potential of distal cytoplasmic CSF3R truncation and missense mutations
    H Zhang
    A Reister Schultz
    S Luty
    A Rofelty
    Y Su
    S Means
    D Bottomly
    B Wilmot
    S K McWeeney
    J W Tyner
    Leukemia, 2017, 31 : 2752 - 2760
  • [25] N-TERMINAL MUTATIONS ACTIVATE THE LEUKEMOGENIC POTENTIAL OF THE MYRISTOYLATED FORM OF C-ABL
    JACKSON, P
    BALTIMORE, D
    EMBO JOURNAL, 1989, 8 (02): : 449 - 456
  • [26] Leukemogenic Risk of Hydroxyurea Therapy as a Single Agent in Polycythemia Vera and Essential Thrombocythemia: N-and K-ras Mutations and Microsatellite Instability in Chromosomes 5 and 7 in 69 Patients
    Despina Mavrogianni
    Nora Viniou
    Evi Michali
    Evangelos Terpos
    John Meletis
    George Vaiopoulos
    Marina Madzourani
    Gerasimos Pangalis
    Xenophon Yataganas
    Dimitris Loukopoulos
    International Journal of Hematology, 2002, 75 : 394 - 400
  • [27] Leukemogenic risk of hydroxyurea therapy as a single agent in polycythemia vera and essential thrombocythemia: N- and K-ras mutations and microsatellite instability in chromosomes 5 and 7 in 69 patients
    Mavrogianni, D
    Viniou, N
    Michali, E
    Terpos, E
    Meletis, J
    Vaiopoulos, G
    Madzourani, M
    Pangalis, G
    Yataganas, X
    Loukopoulos, D
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2002, 75 (04) : 394 - 400
  • [28] Acquired Mitochondrial DNA Mutations in Metastatic Prostatic Adenocarcinoma
    Petros, J. A.
    Arnold, R. S.
    True, L. D.
    Chung, L. W.
    Osunkoya, A. O.
    MODERN PATHOLOGY, 2012, 25 : 234A - 234A
  • [29] Acquired Mitochondrial DNA Mutations in Metastatic Prostatic Adenocarcinoma
    Petros, J. A.
    Arnold, R. S.
    True, L. D.
    Chung, L. W.
    Osunkoya, A. O.
    LABORATORY INVESTIGATION, 2012, 92 : 234A - 234A
  • [30] Question: Please discuss acquired auditory canal stenosis, causes and therapy.
    不详
    LARYNGO-RHINO-OTOLOGIE, 2006, 85 (02) : 147 - 147
12345